These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 8012776
1. P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder. Thomas DJ, Robinson MC, Charlton R, Wilkinson S, Shenton BK, Neal DE. Br J Urol; 1994 May; 73(5):533-7. PubMed ID: 8012776 [Abstract] [Full Text] [Related]
2. Immunohistological expression of p53 in primary pT1 transitional cell bladder cancer in relation to tumour progression. Gardiner RA, Walsh MD, Allen V, Rahman S, Samaratunga ML, Seymour GJ, Lavin MF. Br J Urol; 1994 May; 73(5):526-32. PubMed ID: 8012775 [Abstract] [Full Text] [Related]
3. Abnormalities in p53 and DNA content in transitional cell carcinoma of the bladder. Mellon K, Wilkinson S, Vickers J, Robinson MC, Shenton BK, Neal DE. Br J Urol; 1994 May; 73(5):522-5. PubMed ID: 8012774 [Abstract] [Full Text] [Related]
4. Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study. Leonardi E, Dalla Palma P, Reich A, Caffo O, Luciani L. Anal Cell Pathol; 2000 May; 21(1):21-33. PubMed ID: 11254222 [Abstract] [Full Text] [Related]
5. p53 overexpression as a prognostic factor for advanced stage bladder cancer. Kuczyk MA, Bokemeyer C, Serth J, Hervatin C, Oelke M, Höfner K, Tan HK, Jonas U. Eur J Cancer; 1995 Dec; 31A(13-14):2243-7. PubMed ID: 8652250 [Abstract] [Full Text] [Related]
6. FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer. Mhawech-Fauceglia P, Cheney RT, Fischer G, Beck A, Herrmann FR. Eur J Surg Oncol; 2006 Mar; 32(2):231-7. PubMed ID: 16412606 [Abstract] [Full Text] [Related]
11. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value. Lipponen P, Aaltomaa S, Eskelinen M, Ala-Opas M, Kosma VM. Eur Urol; 1998 Sep; 34(3):237-43. PubMed ID: 9732201 [Abstract] [Full Text] [Related]
12. Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder. Shariat SF, Weizer AZ, Green A, Laucirica R, Frolov A, Wheeler TM, Lerner SP. Urology; 2000 Nov 01; 56(5):735-40. PubMed ID: 11068290 [Abstract] [Full Text] [Related]
14. Immunohistochemical detection of p53 protein in transitional cell carcinoma of the bladder in correlation to DNA ploidy and pathohistological stage and grade. al-Abadi H, Nagel R, Neuhaus P. Cancer Detect Prev; 1998 Nov 01; 22(1):43-50. PubMed ID: 9466048 [Abstract] [Full Text] [Related]
15. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy. Nakopoulou L, Constantinides C, Papandropoulos J, Theodoropoulos G, Tzonou A, Giannopoulos A, Zervas A, Dimopoulos C. Urology; 1995 Sep 01; 46(3):334-40. PubMed ID: 7660508 [Abstract] [Full Text] [Related]
19. Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy. Hemal AK, Khaitan A, Dinda AK, Gupta NP, Seth A, Dogra PN, Nabi G. Urol Int; 2003 Nov 01; 70(1):42-6. PubMed ID: 12566814 [Abstract] [Full Text] [Related]